von Döbeln Gabriella Alexandersson, Onjukka Eva, Ólafsdóttir Halla Sif, Jaraj Sara Jonmarker, Hedman Mattias
Department of Radiation Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, SE-141 52 Huddinge, Sweden.
Clin Transl Radiat Oncol. 2025 Jul 24;54:101022. doi: 10.1016/j.ctro.2025.101022. eCollection 2025 Sep.
Target definition is one of the greatest uncertainties in the radiotherapy process. We aimed to investigate whether a radiologist specialized in head and neck can improve the target definition of hypopharyngeal cancers.
We retrospectively identified 54 patients with hypopharyngeal cancer who received curative-intent radiotherapy between 2009-2015. New target structures were defined incorporating head and neck radiology expertise and updated delineation guidelines. The new structures were subsequently compared both quantitively and qualitatively to the original delineations. Loco-regional failures were analyzed in relation to radiotherapy dose and target volumes.
There was a significant reduction in gross tumour volume (GTV) for the primary tumour, decreasing from 14.4 to 9.2 cm (-47 %), and in clinical target volume (CTV), decreasing from 203.7 to 93.8 cm (-54 %). Mean quantitative values indicated a large overestimation of the original GTV (Dice Coefficient 0.58 ± 0.2 SD, Jaccard index 0.44 ± 0.19 SD, Positive predictive value 0.53 ± 0.24 SD). Only 39 % of the original primary tumour GTV and 19 % of the original lymph node GTV were assessed as acceptable. Twelve patients (22 %) had a locoregional recurrence. In relation to both the original radiation dose and the updated dose distribution, nine recurrences were classified as in field, two as marginal, and one could not be evaluated. The 3-year and 5-year locoregional progression free survival (PFS) was 75.5 % and 66.6 % respectively.
Incorporating radiological expertise in the delineation of hypopharyngeal tumours leads to large changes in tumour volumes and possibly a decrease in radiation volumes which may lead to reduced side effects.
靶区定义是放射治疗过程中最大的不确定因素之一。我们旨在研究头颈专科放射科医生是否能改善下咽癌的靶区定义。
我们回顾性分析了2009年至2015年间接受根治性放疗的54例下咽癌患者。结合头颈放射学专业知识和更新的勾画指南定义新的靶区结构。随后将新结构与原始勾画进行定量和定性比较。分析局部区域失败与放疗剂量和靶区体积的关系。
原发肿瘤的大体肿瘤体积(GTV)显著减小,从14.4立方厘米降至9.2立方厘米(-47%),临床靶区体积(CTV)从203.7立方厘米降至93.8立方厘米(-54%)。平均定量值表明原始GTV存在大量高估(Dice系数0.58±0.2标准差,Jaccard指数0.44±0.19标准差,阳性预测值0.53±0.24标准差)。仅39%的原始原发肿瘤GTV和19%的原始淋巴结GTV被评估为可接受。12例患者(22%)出现局部区域复发。关于原始放射剂量和更新后的剂量分布,9例复发被归类为野内复发,2例为边缘复发,1例无法评估。3年和5年局部区域无进展生存率(PFS)分别为75.5%和66.6%。
将放射学专业知识纳入下咽肿瘤的勾画会导致肿瘤体积发生重大变化,并可能减少放疗体积,这可能会减少副作用。